20
Participants
Start Date
October 16, 2023
Primary Completion Date
June 18, 2026
Study Completion Date
June 18, 2026
Biopsy Procedure
Undergo biopsy
Biospecimen Collection
Undergo collection of blood samples
Computed Tomography
Undergo CT
Magnetic Resonance Imaging
Undergo MRI
Positron Emission Tomography
Undergo PET/MRI or PET/CT
Tuvusertib
Given PO
Ultrasound Imaging
Undergo U/S
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
University of Virginia Cancer Center, Charlottesville
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Mayo Clinic in Rochester, Rochester
Memorial Hospital East, Shiloh
Washington University School of Medicine, St Louis
Siteman Cancer Center-South County, St Louis
Siteman Cancer Center at Christian Hospital, St Louis
Siteman Cancer Center at West County Hospital, Creve Coeur
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
University of Kansas Cancer Center, Kansas City
University of Kansas Hospital-Westwood Cancer Center, Westwood
University of Kansas Hospital-Indian Creek Campus, Overland Park
University of Oklahoma Health Sciences Center, Oklahoma City
UT Southwestern Clinical Center at Richardson/Plano, Richardson
UT Southwestern Simmons Cancer Center - RedBird, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Mayo Clinic Hospital in Arizona, Phoenix
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Mayo Clinic in Florida, Jacksonville
National Cancer Institute (NCI)
NIH